ABSTRACT
INTRODUCTION
Quality of life (QoL) is defined as an individual's perception of his/ her position in life, in thecontext of the culture and value systems, in which he/she lives, in relation to his/her goal, expectation, standards and concerns. 1 Patients who have chronic diseases, in which a long term survival is not at risk, may be more concerned about QoL than longevity. 2, 3 Thyroid disorders are chronic which are highly prevalent even though it is less life threatening. Hypothyroidism is a condition in which the thyroid gland does not make enough thyroid hormones, characterized by a reduction in metabolic rate. The main symptoms of hypothyroidism are fatigue, weakness, increased sensitivity to cold, constipation, unexplained weight gain, dry skin, hair loss or coarse dry hair, muscle cramps and depression. However, most symptoms take years to develop. The slower the metabolism gets, the more obvious the signs and symptoms will become. If hypothyroidism goes untreated, the signs and symptoms could become severe, such as a swollen thyroid gland (goitre), slow thought processes, or dementia. [3] [4] [5] Influence of the QOL in thyroid disease is already published in various studies which have significant importance of it, the patients with hypothyroidism are also in need to check for their depression and anxiety status. Hypothyroid patients may feel discomfort with their neck enlargement which will stress them with the physical appearance; the impact or influence of the disease state in patients living quality is less studied.
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MATERIALS AND METHODS
This is a prospective observational study conducted for a time period of 6 months at the out-patient department of ENT and Endocrinology, Mahatma Gandhi Memorial Hospital, Warangal, Andhrapradesh which is a 1000 bedded multidisciplinary government & tertiary care teaching hospital. This study was approved by the human ethical committee. Patients diagnosed with hypothyroidism for first time irrespective of gender and with 12-40 years of age were included in this study. Patients those who are already on thyroid treatment and on treatment with lipid lowering agents, pregnant & lactating women, with a history of thyroid disease were not included in our study. Study participants those who are not following the treatment and fail to make follow-up were also excluded from the study. Parameters such as TSH, tT3 and tT4 levels during baseline and on review after three months were collected from the patient's lab report. Study participants were explained and given SF-36 questionnaire on baseline and review visit, those who were unable to fill www.ptbreports.org 
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the questionnaire due to cognition intact were not provided with the questionnaire. Scorings were given according to the answers selected by them. The SF-36 questionnaire includes one multi-item scale that assesses eight health status dimensions: 1) Physical functioning: limitations in physical activities because of health problems; 2) Social functioning: limitations in social activities because of physical or emotional problems; 3) Role physical: limitations in usual role activities because of physical health problems; 4) Pain: bodily pain; 5) Mental health: general mental health (psychological distress and well-being); 6) Role emotional: limitations in usual role activities because of emotional problems; 7) Vitality: feeling of energy and fatigue; and 8) General health: general health perceptions. For each of the eight dimensions, item scores were recorded, summed up, and transformed, using a scoring algorithm, into a scale ranging from 0 to 100, with higher scores representing better subjective perception of physical and mental health.Significant difference in thyroid parameters with the treatment is calculated using paired 't' test and the influence of the disease state (thyroid parameters) over the study participants QOL during baseline and review visits was found by stepwise multiple linear regression.
RESULTS AND DISCUSSION
The purpose of this study is to evaluate the relation between the disease state and their quality of life before and after treatment. A total of 30 patients (29 female and 1 male) were included in our study, but only 13 have met with the inclusion criteria. The mean age of the study population was 26.9 ± 8.1 years. Among the study population patients were diagnosed with sub-clinical hypothyroidism (66.66%) and overt hypothyroidism (33.33%).The patients diagnosed with hypothyroidism were treated with (L-thyroxine) and there were significant difference (p=0.0169*) in TSH levels with its treatment. Few study have shown there is no significant change in TSH levels.
Patients living quality was assessed by using SF-36 questionnaire which contains eight subscales for measuring physical, psychologicaland social functioning, scorings were given in percentile value. Overall mean score of study participants for both the baseline and review is represented in (Table 1) which clearly indicates the subjects QOL with hypothyroidism and with its treatment.
Further the influence of disease parameters over the study participant's quality of living was calculated (Table 2) , which shows that TSH is significantly influencing emotional wellbeing (p=0.0327*), emotional well being indicates the mental health of any subjects where the least scoring indicating any nervous feeling and depression all of the time and the highest scoring indicating peacefulness, happy and calm all of the time felt by any person. tT4 levels influencing social functioning (p=0.0299*) and pain (p=0.0309*) scales during baseline. During review after 3 months tT4 levels were found significantly correlating with role limitations due to emotional problem (p=0.0146*).
CONCLUSION
From our study we found that very few QOL scales were significantly influencing with the thyroid parameters during their first and second visit, this is mainly because of the less sample size which requires conducting this study in a large population. Further, QOL is also a major concern.
